Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)
- PMID: 28465460
- DOI: 10.1161/STROKEAHA.117.016669
Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)
Abstract
Background and purpose: The majority of patients enrolled in SWIFT PRIME trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke) had computed tomographic perfusion (CTP) imaging before randomization; 34 patients were randomized after magnetic resonance imaging (MRI).
Methods: Patients with middle cerebral artery and distal carotid occlusions were randomized to treatment with tPA (tissue-type plasminogen activator) alone or tPA+stentriever thrombectomy. The primary outcome was the distribution of the modified Rankin Scale score at 90 days. Patients with the target mismatch profile for enrollment were identified on MRI and CTP.
Results: MRI selection was performed in 34 patients; CTP in 139 patients. Baseline National Institutes of Health Stroke Scale score was 17 in both groups. Target mismatch profile was present in 95% (MRI) versus 83% (CTP). A higher percentage of the MRI group was transferred from an outside hospital (P=0.02), and therefore, the time from stroke onset to randomization was longer in the MRI group (P=0.003). Time from emergency room arrival to randomization did not differ in CTP versus MRI-selected patients. Baseline ischemic core volumes were similar in both groups. Reperfusion rates (>90%/TICI [Thrombolysis in Cerebral Infarction] score 3) did not differ in the stentriever-treated patients in the MRI versus CTP groups. The primary efficacy analysis (90-day mRS score) demonstrated a statistically significant benefit in both subgroups (MRI, P=0.02; CTP, P=0.01). Infarct growth was reduced in the stentriever-treated group in both MRI and CTP groups.
Conclusions: Time to randomization was significantly longer in MRI-selected patients; however, site arrival to randomization times were not prolonged, and the benefits of endovascular therapy were similar.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01657461.
Keywords: brain ischemia; cerebrovascular disorders; magnetic resonance imaging; patient selection; stroke; thrombectomy.
© 2017 American Heart Association, Inc.
Similar articles
-
Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.Stroke. 2015 Oct;46(10):2786-94. doi: 10.1161/STROKEAHA.115.010710. Epub 2015 Aug 27. Stroke. 2015. PMID: 26316344 Clinical Trial.
-
Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.Int J Stroke. 2015 Apr;10(3):439-48. doi: 10.1111/ijs.12459. Int J Stroke. 2015. PMID: 25777831 Free PMC article. Clinical Trial.
-
Predictive Value of RAPID Assessed Perfusion Thresholds on Final Infarct Volume in SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment).Stroke. 2017 Apr;48(4):932-938. doi: 10.1161/STROKEAHA.116.015472. Epub 2017 Mar 10. Stroke. 2017. PMID: 28283606 Clinical Trial.
-
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.Lancet Neurol. 2019 Jan;18(1):46-55. doi: 10.1016/S1474-4422(18)30314-4. Epub 2018 Nov 6. Lancet Neurol. 2019. PMID: 30413385
-
Neuroendovascular Surgery for the Treatment of Ischemic Stroke.Cardiol Rev. 2017 Nov/Dec;25(6):262-267. doi: 10.1097/CRD.0000000000000155. Cardiol Rev. 2017. PMID: 28767503 Review.
Cited by
-
Patients With Acute Ischemic Stroke Who Receive Brain Magnetic Resonance Imaging Demonstrate Favorable In-Hospital Outcomes.J Am Heart Assoc. 2020 Oct 20;9(20):e016987. doi: 10.1161/JAHA.120.016987. Epub 2020 Oct 10. J Am Heart Assoc. 2020. PMID: 33043760 Free PMC article.
-
Predicting Infarct Core From Computed Tomography Perfusion in Acute Ischemia With Machine Learning: Lessons From the ISLES Challenge.Stroke. 2021 Jul;52(7):2328-2337. doi: 10.1161/STROKEAHA.120.030696. Epub 2021 May 7. Stroke. 2021. PMID: 33957774 Free PMC article.
-
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update.Stroke Vasc Neurol. 2023 Dec 29;8(6):e3. doi: 10.1136/svn-2023-002998. Stroke Vasc Neurol. 2023. PMID: 38158224 Free PMC article.
-
Selection of patients with acute vertebrobasilar artery occlusion for endovascular treatment by magnetic resonance imaging.Front Neurol. 2023 Feb 20;14:1084819. doi: 10.3389/fneur.2023.1084819. eCollection 2023. Front Neurol. 2023. PMID: 36891472 Free PMC article.
-
Beyond conventional imaging: A systematic review and meta-analysis assessing the impact of computed tomography perfusion on ischemic stroke outcomes in the late window.Int J Stroke. 2025 Mar;20(3):278-288. doi: 10.1177/17474930241292915. Epub 2024 Nov 10. Int J Stroke. 2025. PMID: 39375904 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical